Total Funding
75
17
Total FundingSeed raised
Growth Score 75 in past quarter
-5 pts
Heat Score 17 in past quarter
-41 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
18678
Andel platform strengthens pharmacy benefits by giving employers an affordable way to include GLP-1s and other brand name medications.
- Jay Bregman: CEO & FounderPast Role: Thimble, President
About the Company
Andel is a healthcare technology platform that enables employers to provide affordable access to cash pay medications—starting with GLP-1 therapies—that are increasingly excluded from traditional pharmacy benefit coverage. As employers continue to reduce coverage for GLP-1s and other brand-name drugs, Andel offers a practical alternative: a
structured way to support employee cash purchases on employer-defined terms that are predictable, trackable, and fair.
